We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Obetocad can be used as a monotherapy or along with UDCA for treatment of patients with primary biliary cholangitis who are unresponsive to UDCA therapy.